Combined Use of Transjugular Intrahepatic Portosystemic Shunt and Transarterial Chemoembolization in the Treatment of Esophageal and Gastric Variceal Bleeding: A Retrospective Study of 80 Patients with Hepatocellular Carcinoma and Portal Hypertension

Xinhua Zou; Miao Xue; Jiaping Li

doi:10.12659/MSM.934436

29 November 2021 : Clinical Research

Combined Use of Transjugular Intrahepatic Portosystemic Shunt and Transarterial Chemoembolization in the Treatment of Esophageal and Gastric Variceal Bleeding: A Retrospective Study of 80 Patients with Hepatocellular Carcinoma and Portal Hypertension

Xinhua Zou^1AB, Miao Xue^1BCDE, Jiaping Li^1EFG*

DOI: 10.12659/MSM.934436

Med Sci Monit 2021; 27:e934436

Authors information Article notes Copyright and License information

Background Material and Methods Results Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Figure 4 Kaplan-Meier plots of median (A) progression-free survival and (B) overall survival in the transjugular intrahepatic portosystemic shunt (TIPS) plus transarterial chemoembolization (TACE) group and endoscopy plus TACE group. GraphPad Prim version 8.0 (GraphPad Software Inc, San Diego, CA, USA) was used for the survival analysis and figure editing.

Back to the Article

Combined Use of Transjugular Intrahepatic Portosystemic Shunt and Transarterial Chemoembolization in the Treatment of Esophageal and Gastric Variceal Bleeding: A Retrospective Study of 80 Patients with Hepatocellular Carcinoma and Portal Hypertension

Your Privacy